Bay Street News, April 21st, 2020

– U.S. patent protection through at least May 2038– Registration-enabling study of cosibelimab in cutaneous squamous cell carcinoma over one-third […]

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility […]

SOUTH SAN FRANCISCO, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), a biopharmaceutical company developing novel […]

NEW YORK, April 21, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the launch of its Nasdaq Cloud Data […]

PHILADELPHIA, April 21, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative […]

SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NYSE: IPHI), a leader in high-speed data movement interconnects, […]

SANTA CLARA, Calif., April 21, 2020 (GLOBE NEWSWIRE) — Inphi Corporation (NYSE: IPHI) today announced its intention to offer, subject […]

DALLAS, April 21, 2020 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (Nasdaq: BLDR) (the “Company”) today announced that it has launched […]

DALLAS, April 21, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced that […]

– Overall response rate of 22% –– Disease control rate of 71% –– Median overall survival of 21 months –– […]